Parents’ and Health Professionals’ Attitudes to Advancing Primary MMR Vaccine Administration from Fifteen to Six Months of Age—A Qualitative Thematic Analysis Embedded in a Randomized Trial

Declining levels and duration of passively acquired maternal antibodies prompted a Danish trial to test the feasibility of advancing administration of the first measles, mumps, and rubella vaccine (MMR1) from 15 to 6 months of age. A trial-embedded qualitative study aimed to understand parents’ (N =...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkedal, Ann-Britt Kiholm, Møller, Julie Elkjær, Stensballe, Lone Graff, Zoffmann, Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861513/
https://www.ncbi.nlm.nih.gov/pubmed/36679912
http://dx.doi.org/10.3390/vaccines11010067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861513/
https://www.ncbi.nlm.nih.gov/pubmed/36679912
http://dx.doi.org/10.3390/vaccines11010067

Ejemplares similares